Security key
05464T104
Axsome Therapeutics, Inc. - Common Stock (AXSM)
CUSIP: 05464T104
Q2 2019 13F Holders as of 30 Jun 2019
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 18,265,403
- Total 13F value
- $470,328,087
- Share change
- +3,562,579
- Put/Call ratio
- 46%
- SEC-reported price per share
- $25.75
- Number of holders
- 107
- Value change
- +$100,449,906
- Number of buys
- 81
- Number of sells
- 31
- Shares outstanding
- 48,932,355
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2019
Institutions
107
Top holders
10
AXSM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2019
Previous quarter: Q1 2019
Axsome Therapeutics, Inc. SEC filings
Axsome Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05464T104
Recent filing periods:
Ownership snapshot
Top reported holders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
31 Mar 2019
13F
Lead comparable stake: 6.7%
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 6.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership
Top 5
RA CAPITAL MANAGEMENT, L.P.
6.7%
BAKER BROS. ADVISORS LP
2.5%
ALETHEA CAPITAL MANAGEMENT, LLC
2.3%
VHCP Management III, LLC
2.2%
Invesco Ltd.
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
6.7%
|
$46,871,000
3,293,789 shares
|
— | 31 Mar 2019 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
2.5%
|
$17,076,000
1,200,000 shares
|
— | 31 Mar 2019 |
| ALETHEA CAPITAL MANAGEMENT, LLC |
13F
Company
|
2.3%
|
$16,228,000
1,140,394 shares
|
— | 31 Mar 2019 |
| VHCP Management III, LLC |
13F
Company
|
2.2%
|
$15,198,000
1,068,044 shares
|
— | 31 Mar 2019 |
| Invesco Ltd. |
13F
Company
|
2.1%
|
$14,948,000
1,050,478 shares
|
— | 31 Mar 2019 |
| VANGUARD GROUP INC |
13F
Company
|
1.8%
|
$12,832,000
901,787 shares
|
— | 31 Mar 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
107
Shares
18,265,403
Rows available
107
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
64
Q2 2019 holders
107
Holder diff
43
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 value | Q2 2019 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend